Actualités

The Pacer US Cash Cows 100 ETF (CBOE:COWZ) is having a solid 2026, up 6.4% year to date and 14.81% over the past year through July 6. Yet a fund built expressly to own America’s biggest cash machines holds zero shares of Apple, arguably the most famous cash generator on the planet. That contradiction is ... Up 14.81% in a Year, COWZ Proves You Don’t Need Apple

CVS Health (NYSE:CVS) agreed to a multi million dollar settlement over alleged false Medicaid and government program claims tied to insulin pen dispensing between 2010 and 2020. The company also received court approval to sell its Omnicare long term care pharmacy business to GenieRx, advancing a planned exit from that segment. These developments affect CVS Health’s regulatory risk profile and the future shape of its pharmacy and health services operations. CVS Health sits at the...

Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.

Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find out.

THC is gaining on rising admissions, strong ambulatory care growth and earnings momentum. But can it sustain gains as expenses keep climbing?

UnitedHealth posted a higher net income margin last quarter, while both companies saw their revenue growth pause after a long expansion.

We recently published Jim Cramer’s Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer. Pharmaceutical retailer CVS Health Corporation (NYSE:CVS) has become one of Cramer’s top stocks in the sector. Throughout this year, the CNBC TV […]

CVS Health Corporation (NYSE:CVS) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer showed a positive sentiment toward the stock, as he said: How about these outsized moves in the health insurers and the drug distributors? Oh, I like these. I bet […]

ELV seeks to recover an estimated $115 million through a CMS lawsuit over Medicare Advantage Star Ratings and disputed bonus payments.

Vltava Fund, a value-focused investment management company, published its investor letter for the second quarter of 2026. A copy of the letter can be downloaded here. The letter explores the growing role of AI and how certain facets of human intelligence may become less valuable economically, while other skills become more important. The author emphasizes […]

ADM, CASY, DVA, CVS and BEN top a list of five non-AI S&P 500 stocks that surged more than 30% in 1H 2026 and still show momentum for 2H.

While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.

Cigna's Evernorth launched AI-powered Pharmacy Forward to speed up specialty prescriptions, cut delays and boost efficiency with a $100M investment.

CVS Health stock has put in a strong three year run, yet the current valuation checks lean toward the shares looking expensive rather than like an obvious bargain. CVS Health has returned 69.2% over the past three years, which puts extra focus on whether the recent share price strength is now running ahead of fundamentals. The expansion of CVS Health's GLP-1 program and Medicare-related offerings can support expectations for future business volume. At the same time, regulatory probes and...

In recent days, coverage on CVS Health has highlighted its role in America250 celebrations, expanding menopause and preventive care initiatives, and supporting Medicare obesity drug access, alongside fresh regulatory scrutiny of its Caremark pharmacy benefit manager operations. At the same time, analysts are pointing to CVS Health’s pattern of outperforming earnings estimates as a potential driver of heightened optimism around its upcoming results and near-term business performance. We’ll...

CVS Health (NYSE:CVS) is partnering with America250 to support community events tied to the United States’ 250th anniversary celebrations. The company plans to help lead community engagement at block parties and public celebrations across major cities. CVS Health intends to use its workforce and local footprint to provide health screenings and volunteer support during these events. CVS Health, with its shares recently trading at $104.81, is adding a fresh public health angle to the...

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Express Scripts, Caremark and Optum Rx sued the FTC after the agency accused them of driving up the cost of insulin. But the countersuit is being put to bed now that the PBMs are settling with regulators.

CVS Heath's Siddharth ‘Sid’ Tenneti joins Ashley Mastronardi on NYSE Live to discuss their support for America250

CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 12.4% gain over the past six months, beating the S&P 500 by 5.6 percentage points.

Joel Greenblatt's Magic Formula ranks stocks on earnings yield and return on capital, but for retirees those two numbers can point straight toward disaster. Three stocks cleared the screen, and only one survives when income reliability and volatility enter the equation.

The stock is already up 30% this year.

Salesforce Inc. (NYSE:CRM) ranks among the best set-it-and-forget-it stocks to buy right now. On June 12, TD Cowen reaffirmed its $240 price objective and Buy rating on Salesforce Inc. (NYSE:CRM). The update came after the firm hosted an investor dinner with new IR Senior Director Lauren O’Brien and the Vice President of Investor Relations, Valmik […]

Pfizer's CFO joins Nike, Wendy's hires Potbelly Sandwiches' CFO, Airwallex's new CFO boomerangs back to the company and more.

CVS Health’s implied fair value has been updated from US$102.85 to US$105.38 per share, signaling a modest reset in how analysts are framing the stock. Behind this move, recent research highlights stronger engagement potential from GLP 1 programs, improving sentiment toward managed care, and an earnings story that some bullish analysts view as supported by margin recovery and policy visibility, even as more cautious voices flag ongoing risks. Keep reading to see what is driving this evolving...

Florida's Attorney General has opened an investigation into CVS Health's (NYSE:CVS) Caremark pharmacy benefit manager for alleged anticompetitive practices. The probe focuses on claims of steering patients, preferential reimbursement rates, and burdensome audits that may disadvantage independent pharmacies. The investigation centers on Caremark's role in managing prescription drug benefits and its interactions with pharmacies across Florida. CVS Health sits at the intersection of retail...

CI is evolving beyond traditional insurance, using AI, specialty pharmacy and healthcare services to drive growth and sharpen its business focus.

ARS Pharmaceuticals stock collapsed Thursday after CVS Caremark declined to add its epinephrine spray, Neffy, to its formulary.

(Bloomberg) -- Moving from Pfizer Inc. to Nike Inc. may seem like an unusual career shift for a finance chief. For David Denton, it marks a return to the consumer sector after four years in pharmaceuticals.Most Read from BloombergInvestor Who Scored 900% Win in 2008 Crisis Has New Big Short BetGrand Ole Opry House Up For Sale by Owner Ryman HospitalityMicron Shares Soar After AI-Fueled Forecast Shatters ProjectionsStocks Slide as Wall Street Gets AI Wake-Up Call: Markets WrapStocks Erase Gains a